Palliative and oncological management of pancreatic cancer
HAMDAN MEDICAL JOURNAL · 2015
DOI: 10.7707/hmj.438 ↗Kurz gefasst
Fachartikel in der Zeitschrift HAMDAN MEDICAL JOURNAL, 2015. Verfasst von Tom Gallagher und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Pancreatic cancer is among the most difficult cancers to manage owing to a lack of early symptoms, early metastatic spread and debilitating cachexia quite unlike that seen in most other tumours. Up to 80% of patients will have metastatic or locally advanced disease at the time of presentation and therefore the mainstay of management in the majority of cases is symptomatic with or without the addition of systemic treatment, depending on patient factors. This review focuses on oncological strategies for advanced pancreatic cancer from standard gemcitabine-based therapies to the more recently reported molecular profiling-based strategies that are becoming the mainstay of treatment in recent years. In a disease with such a guarded prognosis, symptom management and maximizing quality of life is of utmost importance; here, we also review the multidisciplinary management of biliary obstruction, gastric outlet obstruction, pain, cachexia and the risk of thromboembolism.
Zitieren
APA
Gallagher, T., & Parks, R. (2015). Palliative and oncological management of pancreatic cancer. HAMDAN MEDICAL JOURNAL. https://doi.org/10.7707/hmj.438
Vancouver
Gallagher T, Parks R. Palliative and oncological management of pancreatic cancer. HAMDAN MEDICAL JOURNAL. 2015. doi:10.7707/hmj.438
BibTeX
@article{Gallagher2015,
author = {Gallagher, Tom and Parks, Rowan},
title = {Palliative and oncological management of pancreatic cancer},
journal = {HAMDAN MEDICAL JOURNAL},
year = {2015},
doi = {10.7707/hmj.438}
}
EUVIMED